Aperio (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Aperio

Founded 1999

Vista, United States 86 employees Debt Financing Total: $61.65M Biotechnology, Health Care +1

Aperio, a biotechnology and healthcare startup based in the United States, was founded in 1999 and is headquartered in Vista, CA, approximately 35 miles north of San Diego. The company has developed technology to digitize and securely share glass slides, revolutionizing the practice of pathology in hospitals, reference labs, pharmaceutical, and research institutions globally. Aperio's ePathology Solutions, including the NETWORK and PRECISION tools, empower pathologists with advanced analytic capabilities, real-time viewing, and collaboration features. The company's web-based software platform ensures integration with existing systems for transparency, consistency, and efficiency in pathology operations. In its most recent funding round, Aperio secured a $5.82M debt financing investment on 09 August 2012. The company serves a crucial role in supporting patient care, personalized medicine, and research through its innovative solutions. For further details on clearance updates and specific product indications, interested parties can visit www.aperio.com. With its strong track record and innovative products, Aperio presents an exciting opportunity for potential investors in the biotechnology and healthcare sectors.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	••••••	-		09 Aug 2012
Series C	••••••	5	•••• ••••	13 Mar 2008
Series C	••••••	2		30 May 2007
Venture Round	••••••	2		08 Dec 2005
Series B	••••••	1		02 Nov 2004

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

••••••

09 Aug 2012

Series C

••••••

•••• ••••

13 Mar 2008

Series C

••••••

30 May 2007

Venture Round

••••••

08 Dec 2005

Series B

••••••

02 Nov 2004

FAQ About Aperio

For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio products are transforming the practice of pathology in hospitals, reference labs and pharmaceutical and research institutions around the world. From the moment glas...

Aperio was founded in 1999.

Aperio is headquartered in Vista, United States.

Aperio operates in the following industries: Biotechnology, Health Care, Pharmaceutical.

Aperio has approximately 86 employees.

Aperio has completed 6 funding rounds, raising a total of $61.65M. The latest funding stage is Debt Financing.

Top alternatives and competitors to Aperio include PathoPulse, Grey Slide Imaging, HistoWiz, Virasoft Corporation, MAWD Pathology Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Aperio and PathoPulse are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Aperio

General Information

Track Aperio

Discover More

About Aperio

Funding Rounds & Investors (6)

Aperio Alternatives & Competitors

FAQ About Aperio

Don't just browse. Track.